echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > China’s first ambroxol hydrochloride spray was officially approved, Luoxin Pharmaceutical’s exclusive research and development fills the gap in the children’s drug market

    China’s first ambroxol hydrochloride spray was officially approved, Luoxin Pharmaceutical’s exclusive research and development fills the gap in the children’s drug market

    • Last Update: 2021-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 2, 2021, Luoxin Pharmaceutical Group Co.



    Exclusive formulation fills the gap in the market


    Luoxin Pharmaceuticals actively responds to the national call and is guided by the clinical needs of pediatrics.


    Accompanying the occurrence of influenza and other diseases, the symptoms of coughing and sputum in children are on average 2 times a year, but there is no clinically dedicated medicine for expectorating children between 2-6 years old


    As the first and only child-specific expectorant spray in China, the approval of ambroxol hydrochloride spray is expected to solve the problem that existing dosage forms cannot meet clinical needs, and enable high-quality innovative drugs to better serve The field of medicine for children in China


    Classic expectorant products

    Occupies 3/4 of the total expectorant market


    As a classic drug, ambroxol hydrochloride is widely used not only in respiratory medicine, but also in pediatrics.


    According to data from IQVIA and Meinenet, the global sales of ambroxol hydrochloride in 2020 will be 587 million U.


    Focus on the field of respiratory diseases

    Innovate for clinical needs


    The company said that ambroxol hydrochloride spray is another major product in the field of respiratory diseases, which has opened up the children's drug market, which is conducive to further enhancing market competitiveness and expanding market share


    Liu Zhenteng, Chairman and CEO of Luoxin Pharmaceutical, said: “We are very pleased to see the approval of ambroxol hydrochloride spray.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.